PONOI Capital, L.P., 10% Owner, Director at NGM BIOPHARMACEUTICALS INC (NGM), bought 58,106 shares at $13.48 ($779K) on 2022-05-20, disclosed to the SEC on 2022-05-23.
Open-market purchase of $779k NGM by 10% Owner, Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.25 | 682 | $9K | 1.2% |
| 2 | $13.25 | 19,984 | $265K | 34.0% |
| 3 | $13.48 | 628 | $8K | 1.1% |
| 4 | $13.48 | 18,406 | $248K | 31.9% |
| 5 | $13.48 | 18,406 | $248K | 31.9% |
| Total | $13.40 avg | 58,106 |
| $779K |
| 100% |
| Filing → |